AGM/EGM4 Sept 2026, 01:36 pm
Biogen Pharmachem Announces 31st AGM on Sep 29, 2026
AI Summary
Biogen Pharmachem Industries Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice of the 31st Annual General Meeting (AGM). The AGM is scheduled to be held on Tuesday, September 29, 2026, at 04:00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). Key agenda items include the adoption of audited financial statements for FY2025-26, the reappointment of a director retiring by rotation, and the reappointment of M/s. Goenka Mehta & Associates as statutory auditors for a term of five years.
Key Highlights
- Annual Report for FY2025-26 submitted.
- 31st AGM scheduled for September 29, 2026, via VC/OAVM.
- Audited financial statements for FY2025-26 to be adopted.
- Statutory auditors to be reappointed for five years.
- Director Kelash Bunkar up for re-appointment.
Price Impact
More from BIOGEN